Last Updated:
3:50 pm
Monday, June 23, 2025
Cynata Therapeutics Ltd. engages in the development and commercialization of therapeutic products. It focuses on proprietary mesenchymal stem cell technology. The company was founded on March 12, 2003 and is headquartered in Carlton, Australia.
asx-cyp
Market Cap
AU$40.67M
Volume
445030
Open
0.17
AU$
High
0.17
AU$
Low
0.16
AU$
Shares On Issue
184M
52 Week Low
0.14
AU$
52 Week High
0.295
AU$
Website
www.cynata.com
Consensus
N/A
Last Report Date
N/A
Next Report Date
N/A
Next Dividend date
N/A
Short Sell
N/A
Short Sell Change (1mth)
N/A
Free ASX Market Outlook & Top Stock Picks for 2025
Instantly access our exclusive report and see which stocks our analysts are backing for growth this year.
Download Free Report
Related
Our friendly team is here to help.
If you have any questions or feedback about our service, please feel free to contact us.
© Australian Stock Report Pty Ltd. All rights reserved